Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer-Reference-Cited by-同舟云学术

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer

Published:2020-05-01 Issue:5 Volume:6 Page:735
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Dess Robert T.¹,Sun Yilun¹²,Jackson William C.¹,Jairath Neil K.¹,Kishan Amar U.³,Wallington David G.¹,Mahal Brandon A.⁴,Stish Bradley J.⁵,Zumsteg Zachery S.⁶,Den Robert B.⁷,Hall William A.⁸,Gharzai Laila A.¹,Jaworski Elizabeth M.¹,Reichert Zachary R.⁹,Morgan Todd M.¹⁰,Mehra Rohit¹¹,Schaeffer Edward M.¹²,Sartor Oliver¹³,Nguyen Paul L.⁴,Lee William Robert¹⁴,Rosenthal Seth A.¹⁵,Michalski Jeff M.¹⁶,Schipper Matthew J.¹²,Dignam James J.¹⁷,Pisansky Thomas M.⁵,Zietman Anthony L.¹⁸,Sandler Howard M.⁶,Efstathiou Jason A.¹⁸,Feng Felix Y.¹⁹²⁰²¹,Shipley William U.¹⁸,Spratt Daniel E.¹

Affiliation:

1. Department of Radiation Oncology, University of Michigan, Ann Arbor

2. Department of Biostatistics, University of Michigan, Ann Arbor

3. Department of Radiation Oncology, University of California, Los Angeles

4. Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

5. Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

6. Department of Radiation Oncology, Cedars-Sinai Medical Center, West Hollywood, California

7. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania

8. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee

9. Department of Medicine, University of Michigan, Ann Arbor

10. Department of Urology, University of Michigan, Ann Arbor

11. Department of Pathology, University of Michigan, Ann Arbor

12. Department of Urology, Northwestern University, Chicago, Illinois

13. Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana

14. Department of Radiation Oncology, Duke Health, Durham, North Carolina

15. Department of Radiation Oncology, Sutter Medical Group, Sacramento, California

16. Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri

17. Department of Public Health Sciences, University of Chicago, Chicago, Illinois

18. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts

19. Department of Radiation Oncology, University of California, San Francisco

20. Department of Urology, University of California, San Francisco

21. Department of Medicine, University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2763311/jamaoncology_dess_2020_oi_200003.pdf

Reference32 articles.

1. Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015.;Mahal;JAMA,2019

2. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.;Stephenson;J Clin Oncol,2005

3. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.;Abdollah;Eur Urol,2015

4. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy.;Tendulkar;J Clin Oncol,2016

5. Radiation with or without antiandrogen therapy in recurrent prostate cancer.;Shipley;N Engl J Med,2017

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?;Strahlentherapie und Onkologie;2024-01-25

2. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774);European Urology;2024-01

3. Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer;Cancer Treatment Reviews;2024-01

4. Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU);Cancer Treatment Reviews;2023-11

5. Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma;Oncology Reviews;2023-09-13